Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Research

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF), founded in 1994 and based in Shanghai, China, is a comprehensive pharmaceutical enterprise. The company is actively engaged in the research, development, manufacturing, and sale of pharmaceutical products, serving markets across Mainland China and internationally. Its diverse operations are structured into five main segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Services, Pharmaceutical Distribution and Retail, and Other Business activities. Within its pharmaceutical portfolio, Fosun Pharma focuses on critical therapeutic areas such as oncology, immune system modulation, metabolic disorders, gastrointestinal conditions, and central nervous system ailments. Beyond its drug offerings, the company also provides a range of medical equipment and diagnostic solutions. Furthermore, SFOSF is involved in delivering healthcare services and managing hospitals, alongside its wholesale and retail distribution of medicines.

Market snapshot

Symbol
SFOSF
Price
$2.02
Day change
0.00%
Market cap
$57.5B
P/E ratio
16.51x
52-week range
1.955-3.5
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Peer companies

  • Bangkok Dusit Medical Services Public Company Limited (BDULF)
  • Bangkok Dusit Medical Services Public Company Limited (BDUUF)
  • Swedish Orphan Biovitrum AB (publ) (BIOVF)
  • CSPC Pharmaceutical Group Limited (CSPCY)
  • Eisai Co., Ltd. (ESAIY)
  • Eisai Co., Ltd. (ESALF)
  • Grifols, S.A. (GIFLF)
  • Orion Oyj (ORINF)

Open Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.